Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS S&P 500 Scored & Screened UCITS ETF hEUR acc
IE00BHXMHQ65 · IE00BHXMHQ65 · EUR · domicile Ireland
Equity · United States · Large cap · Sustainable / ESGEUR-hedged share classSFDR art. 8
Index tracked: S&P 500 Scored & Screened Hedged to EUR Index (Net Total Return)
- TER
- 0.13%+ trans. 0.00%
- Fund size
- 899 m EUR
- Tracking difference
- +0.10%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical (full replication)
- Income
- Accumulating
Launch 25 Mar 2019 · costs from the KID as of 2 Sept 2026 · 325 securities held · 9 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and seeks to track performance of the S&P 500 Scored & Screened Hedged to EUR Index (Net Total Return) (the 'Index'). The Index is an equity Index calculated, maintained and published by international Index supplier S&P Indices and is denominated in USD. It tracks the movements of the 500 leading companies listed on markets in the USA but available to investors globally. The Index is a broad-based, market cap-weighted index that is designed to generate exposure to best-in-class environmental, social and governance ('ESG') US…
Performance since series start (in euro) — base 100
25 Mar 2019 → 8 Sept 2026 · dividends reinvested where declared by the issuer
Returns in euro
| 1 year | +20.0% |
| 3 years | +67.5% |
| 5 years | +66.3% |
| 10 years | series too young |
| Since series start | +172.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 13.20% | 15.03% | 17.28% |
| Max drawdown | −10.01% | −19.56% | −26.43% |
| Sharpe | 1.29 | 1.01 | 0.54 |
| Sortino | 1.91 | 1.48 | 0.77 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BHXMHQ65 · IE00BHXMHQ651
RebalixIE00BHXMHQ65 · IE00BHXMHQ65 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +16.01% | +15.91% | +0.10% |
| 2024 | +21.58% | +21.47% | +0.10% |
| 2023 | +23.93% | +23.83% | +0.10% |
| 2022 | −20.55% | −20.61% | +0.05% |
| 2021 | +30.06% | +30.03% | +0.03% |
Holdings
Portfolio as declared by the issuer · 19 Aug 2026 · 325 securities · top-10 weight = 40.0%
| Top holdings | Weight |
|---|---|
| 12.7% | |
| 8.7% | |
| 4.9% | |
| 3.9% | |
| 2.5% | |
| 2.4% | |
| 1.5% | |
| 1.2% | |
| 1.1% | |
| 1.1% |
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
5ESGE · Borsa Italiana (ETFplus)
S5SG · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 18 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
Prospectus · www.ubs.com/2/e/files/ubs_irl_etf_plc_peit.pdf
The live sheet, always up to date
rebalix.com/en/etf/IE00BHXMHQ65
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BHXMHQ65
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BHXMHQ65 · IE00BHXMHQ652